Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 16 studies | 71% ± 18% | |
| astrocyte | 15 studies | 40% ± 17% | |
| oligodendrocyte precursor cell | 15 studies | 59% ± 19% | |
| glutamatergic neuron | 12 studies | 62% ± 18% | |
| fibroblast | 11 studies | 29% ± 10% | |
| GABAergic neuron | 10 studies | 61% ± 18% | |
| interneuron | 6 studies | 66% ± 14% | |
| Mueller cell | 6 studies | 61% ± 12% | |
| neuron | 5 studies | 46% ± 14% | |
| endothelial cell | 5 studies | 43% ± 14% | |
| epithelial cell | 4 studies | 29% ± 9% | |
| granule cell | 4 studies | 68% ± 27% | |
| microglial cell | 4 studies | 39% ± 13% | |
| amacrine cell | 4 studies | 44% ± 10% | |
| retinal pigment epithelial cell | 4 studies | 36% ± 6% | |
| adventitial cell | 4 studies | 26% ± 1% | |
| GABAergic interneuron | 3 studies | 46% ± 16% | |
| adipocyte | 3 studies | 20% ± 3% | |
| GABAergic amacrine cell | 3 studies | 34% ± 8% | |
| glycinergic amacrine cell | 3 studies | 34% ± 7% | |
| podocyte | 3 studies | 81% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 98% | 5382.70 | 240 / 245 | 100% | 296.51 | 502 / 502 |
| brain | 99% | 14139.04 | 2621 / 2642 | 94% | 103.50 | 662 / 705 |
| adrenal gland | 97% | 4112.85 | 250 / 258 | 87% | 141.27 | 201 / 230 |
| breast | 88% | 4455.55 | 406 / 459 | 71% | 27.84 | 799 / 1118 |
| kidney | 92% | 3851.54 | 82 / 89 | 60% | 38.76 | 545 / 901 |
| thymus | 76% | 2102.36 | 494 / 653 | 60% | 29.50 | 362 / 605 |
| bladder | 90% | 2399.71 | 19 / 21 | 38% | 12.49 | 192 / 504 |
| uterus | 86% | 4996.63 | 147 / 170 | 36% | 17.08 | 164 / 459 |
| ureter | 0% | 0 | 0 / 0 | 100% | 11.77 | 1 / 1 |
| adipose | 97% | 5687.65 | 1167 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 67% | 3409.08 | 648 / 966 | 30% | 8.59 | 157 / 527 |
| skin | 62% | 6127.53 | 1122 / 1809 | 35% | 18.18 | 164 / 472 |
| blood vessel | 96% | 4016.94 | 1288 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 61% | 2165.38 | 884 / 1445 | 33% | 10.04 | 60 / 183 |
| pancreas | 15% | 267.36 | 49 / 328 | 69% | 23.58 | 123 / 178 |
| heart | 74% | 3855.14 | 636 / 861 | 0% | 0 | 0 / 0 |
| stomach | 35% | 1735.96 | 125 / 359 | 38% | 13.75 | 110 / 286 |
| muscle | 68% | 2083.79 | 543 / 803 | 0% | 0 | 0 / 0 |
| lung | 16% | 361.74 | 90 / 578 | 33% | 10.83 | 378 / 1155 |
| ovary | 17% | 776.70 | 30 / 180 | 11% | 2.98 | 48 / 430 |
| spleen | 23% | 528.43 | 55 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 2.51 | 6 / 45 |
| liver | 0% | 0 | 0 / 226 | 8% | 2.19 | 31 / 406 |
| eye | 0% | 0 | 0 / 0 | 5% | 1.30 | 4 / 80 |
| peripheral blood | 0% | 1.39 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0001558 | Biological process | regulation of cell growth |
| GO_0010951 | Biological process | negative regulation of endopeptidase activity |
| GO_0021953 | Biological process | central nervous system neuron differentiation |
| GO_0001764 | Biological process | neuron migration |
| GO_0007155 | Biological process | cell adhesion |
| GO_0022008 | Biological process | neurogenesis |
| GO_0010977 | Biological process | negative regulation of neuron projection development |
| GO_0007399 | Biological process | nervous system development |
| GO_0010812 | Biological process | negative regulation of cell-substrate adhesion |
| GO_0005615 | Cellular component | extracellular space |
| GO_0016528 | Cellular component | sarcoplasm |
| GO_0031594 | Cellular component | neuromuscular junction |
| GO_0014069 | Cellular component | postsynaptic density |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0033268 | Cellular component | node of Ranvier |
| GO_0004869 | Molecular function | cysteine-type endopeptidase inhibitor activity |
| GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
| GO_0008191 | Molecular function | metalloendopeptidase inhibitor activity |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SPOCK1 |
| Protein name | Alternative protein SPOCK1 SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1 Testican-1 (Protein SPOCK) |
| Synonyms | TIC1 SPOCK TICN1 |
| Description | FUNCTION: May play a role in cell-cell and cell-matrix interactions. May contribute to various neuronal mechanisms in the central nervous system. |
| Accessions | L8ECB3 D6RAM7 ENST00000510689.5 D6RB21 Q08629 ENST00000394945.6 ENST00000505690.1 |